Prosecution Insights
Last updated: May 29, 2026
Application No. 17/501,386

ASSEMBLY AND SYSTEM INCLUDING A BIOLOGICAL SAMPLE TREATMENT CHAMBER

Final Rejection §102§103
Filed
Oct 14, 2021
Priority
May 14, 2019 — provisional 62/847,388 +2 more
Examiner
BOYER, RANDY
Art Unit
1771
Tech Center
1700 — Chemical & Materials Engineering
Assignee
VENTANA MEDICAL SYSTEMS, INC.
OA Round
2 (Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
78%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
641 granted / 913 resolved
+5.2% vs TC avg
Moderate +8% lift
Without
With
+8.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
25 currently pending
Career history
937
Total Applications
across all art units

Statute-Specific Performance

§101
3.3%
-36.7% vs TC avg
§103
76.7%
+36.7% vs TC avg
§102
9.5%
-30.5% vs TC avg
§112
8.3%
-31.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 913 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The Information Disclosure Statements filed 8 July 2024 and 8 September 2025 fails to comply with the provisions of 37 CFR 1.97, 1.98 and MPEP § 609 because the foreign patent documents indicated with Election/Restrictions Applicant’s election without traverse of claims 1-14 in the reply filed on 11 July 2025 is acknowledged. Claims 15-20 are withdrawn from further consideration by the examiner as being drawn to a non-elected invention. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office Action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1 and 3 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Tacha (US 9,945,763) (“D1” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407). With respect to claims 1 and 3, Examiner adopts the detailed reasoning set forth in the IPR referenced above1, a copy of which is being supplied with this Office Action. Claims 1, 8, and 9 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Angros-1 (US 2018/0017471) (“D2” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407). With respect to claims 1, 8, and 9, Examiner adopts the detailed reasoning set forth in the International Preliminary Report referenced above2, a copy of which is being supplied with this Office Action. Claims 1 and 4 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Cappi (EP 3427829 A1) (“D3” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407). With respect to claims 1 and 4, Examiner adopts the detailed reasoning set forth in the International Preliminary Report referenced above3, a copy of which is being supplied with this Office Action. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office Action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 2, 6, 7, and 10 are rejected under 35 U.S.C. 103 as being unpatentable over Tacha (US 9,945,763) (“D1” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407). With respect to claims 2, 6, 7, and 10, Examiner adopts the detailed reasoning set forth in the International Preliminary Report referenced above4, a copy of which is being supplied with this Office Action. Claims 5, 11, 13, and 14 are rejected under 35 U.S.C. 103 as being unpatentable over Tacha (US 9,945,763) (“D1” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407) in view of Angros-2 (US 2010/0068757) (“D5” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407)). With respect to claims 5, 11, 13, and 14, Examiner adopts the detailed reasoning set forth in the International Preliminary Report referenced above5, a copy of which is being supplied with this Office Action. Claim 12 is rejected under 35 U.S.C. 103 as being unpatentable over Tacha (US 9,945,763) (“D1” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407) in view of Angros-2 (US 2010/0068757) (“D5” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407)) and Cappi (EP 3427829 A1) (“D3” as indicated in the “International Preliminary Report on Patentability” (“IPR”) issued 16 November 2021 in corresponding international application PCT/EP2020/063407). With respect to claim 12, Examiner adopts the detailed reasoning set forth in the International Preliminary Report referenced above6, a copy of which is being supplied with this Office Action. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Randy Boyer whose telephone number is (571) 272-7113. The examiner can normally be reached Monday through Friday from 10:00 A.M. to 7:00 P.M. (EST). If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Prem C. Singh, can be reached at (571) 272-6381. The fax number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Randy Boyer/ Primary Examiner, Art Unit 1771 1 Claims 1 and 3 of the instant application corresponding to claims 1 and 5, respectively, of the IPR. 2 Claims 1, 8, and 9 of the instant application corresponding to claims 1, 20, and 23, respectively, of the IPR. 3 Claims 1 and 4 of the instant application corresponding to claims 1 and 8, respectively, of the IPR. 4 Claims 2, 6, 7, and 10 of the instant application corresponding to claims 2, 10, 16, and 25, respectively, of the IPR. 5 Claims 5, 11, 13, and 14 of the instant application corresponding to claims 9, 26, 29, and 31, respectively, of the IPR. 6 Claim 12 of the instant application corresponding to claim 28 of the IPR.
Read full office action

Prosecution Timeline

Oct 14, 2021
Application Filed
Oct 22, 2025
Non-Final Rejection mailed — §102, §103
Jan 26, 2026
Response Filed
May 26, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637653
IN-LINE PRODUCT MONITORING IN INTEGRATED CONTINUOUS BIO-MANUFACTURING
5y 7m to grant Granted May 26, 2026
Patent 12630769
CO-CRACKING PYOIL WITH ETHANE
4y 6m to grant Granted May 19, 2026
Patent 12630772
HYDROTHERMAL PURIFICATION PROCESS
2y 7m to grant Granted May 19, 2026
Patent 12624293
METHOD AND SYSTEMS FOR TRANSPORTING BITUMEN IN SOLIDIFIED FORM
2y 11m to grant Granted May 12, 2026
Patent 12623980
SEPARATION OF HYDROGEN, METHANE, ETHANE, AND PROPANE IN NAPHTHA TO ETHANE AND PROPANE FRACTIONATION SECTION BASED ON A DIVIDING WALL FRACTIONATION COLUMN INTEGRATION
2y 6m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
78%
With Interview (+8.1%)
3y 3m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 913 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month